Efficacy and safety of Hemangiol solution in the treatment of high risk infantile hemangioma. A Multinational single arm study
Efficacy and safety of Hemangiol solution in the treatment of high risk infantile hemangioma. A Multinational single arm study
Efficacy and safety of Hemangiol solution in the treatment of high risk infantile hemangioma. A Multinational single arm study
Status
Status :
Completed
Type of study
Phase III
Min. Age
-
Max. Age
-
Gender
All
Therapeutic area :
Dermatology
Disease :
Hemangioma
Study medication :
Propranolol (Hemangiol®)
Phase :
Phase III
Start Date :
29 June 2015
End date :
21 February 2017
Study ID :
V00400 SB 302
EudraCT/CTIS number :
2014-005555-80
Send by email